Boston Scientific Announces Results For Third Quarter 2015

Go back to Boston Scientific Announces Results For Third Quarter 2015

Boston Scientific (BSX) Reports Strong 3Q Results; Needham & Company Reiterates Buy

October 28, 2015 3:56 PM EDT

Needham & Company reiterated a Buy rating on Boston Scientific (NYSE: BSX), and raised the price target to $22.00 (from $21.00), following the company's 3Q15 earnings results. Revenue was $1.888B vs. consensus of $1.861B and EPS was $0.24 vs. consensus of $0.23.

Analyst Mike Matson commented, "BSX's... More

Boston Scientific (BSX) Tops Q3 EPS by 1c

October 28, 2015 6:32 AM EDT

Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.24, $0.01 better than the analyst estimate of $0.23. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.86 billion.

Boston Scientific sees Q4 2015 EPS of $0.23-$0.25, versus the consensus of $0.26. Boston Scientific sees Q4 2015... More